Credit Suisse Ag Syndax Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 86,223 shares of SNDX stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,223

Previous 72,775 18.48%

Holding current value

$1.41 Million

Previous $1.57 Million 30.53%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$19.71 - $24.57 $265,060 - $330,417	13,448 Added 18.48%	86,223 $2.05 Million
Q4 2023 Feb 08, 2024	BUY	$11.39 - $21.67 $18,622 - $35,430	1,635 Added 2.3%	72,775 $1.57 Million
Q3 2023 Nov 13, 2023	SELL	$14.52 - $21.77 $163,320 - $244,868	-11,248 Reduced 13.65%	71,140 $1.03 Million
Q2 2023 Aug 11, 2023	BUY	$19.35 - $22.31 $516,432 - $595,431	26,689 Added 47.92%	82,388 $1.72 Million
Q1 2023 May 10, 2023	BUY	$20.66 - $28.98 $21,837 - $30,631	1,057 Added 1.93%	55,699 $1.18 Million
Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $194,903 - $247,784	9,443 Added 20.89%	54,642 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$18.51 - $24.79 $230,764 - $309,056	12,467 Added 38.09%	45,199 $1.09 Million
Q2 2022 Aug 12, 2022	BUY	$13.64 - $19.48 $42,188 - $60,251	3,093 Added 10.44%	32,732 $630,000
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $14,320 - $21,374	-965 Reduced 3.15%	29,639 $516,000
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $60,813 - $89,722	3,993 Added 15.01%	30,604 $670,000
Q3 2021 Nov 12, 2021	BUY	$13.87 - $19.8 $36,977 - $52,786	2,666 Added 11.13%	26,611 $508,000
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $26,142 - $49,050	-1,948 Reduced 7.52%	23,945 $411,000
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $571,131 - $728,429	-29,623 Reduced 53.36%	25,893 $578,000
Q4 2020 Feb 12, 2021	SELL	$15.1 - $26.44 $91,490 - $160,199	-6,059 Reduced 9.84%	55,516 $1.24 Million
Q3 2020 Nov 13, 2020	BUY	$13.39 - $17.48 $129,092 - $168,524	9,641 Added 18.56%	61,575 $908,000
Q2 2020 Aug 12, 2020	BUY	$8.94 - $20.98 $464,289 - $1.09 Million	51,934 New	51,934 $770,000

Others Institutions Holding SNDX

# of Institutions

232

Shares Held

96.9M

Call Options Held

1.39M

Put Options Held

543K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $927M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account